Published in J Neurosci on April 15, 2015
Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics. Br J Pharmacol (2016) 0.84
Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain. Purinergic Signal (2015) 0.81
Basal adenosine modulates the functional properties of AMPA receptors in mouse hippocampal neurons through the activation of A1R A2AR and A3R. Front Cell Neurosci (2015) 0.76
The chemokine CXCL16 modulates neurotransmitter release in hippocampal CA1 area. Sci Rep (2016) 0.75
Transmission pathways and mediators as the basis for clinical pharmacology of pain. Expert Rev Clin Pharmacol (2016) 0.75
Regulation of neuronal chloride homeostasis by neuromodulators. J Physiol (2016) 0.75
Potentiation of Amitriptyline Anti-Hyperalgesic-Like Action By Astroglial Connexin 43 Inhibition in Neuropathic Rats. Sci Rep (2016) 0.75
CD73 Controls Extracellular Adenosine Generation in the Trigeminal Nociceptive Nerves. J Dent Res (2017) 0.75
Native KCC2 interactome reveals PACSIN1 as a critical regulator of synaptic inhibition. Elife (2017) 0.75
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain (1988) 15.15
Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain (2007) 6.98
Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol (1980) 6.82
Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature (2003) 4.50
The phasor approach to fluorescence lifetime imaging analysis. Biophys J (2007) 4.05
Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci (2002) 3.32
Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis. Nat Neurosci (2013) 2.37
Roles of the cation-chloride cotransporters in neurological disease. Nat Clin Pract Neurol (2008) 2.19
High salt intake increases blood pressure via BDNF-mediated downregulation of KCC2 and impaired baroreflex inhibition of vasopressin neurons. Neuron (2015) 2.14
Two developmental switches in GABAergic signalling: the K+-Cl- cotransporter KCC2 and carbonic anhydrase CAVII. J Physiol (2004) 2.11
Molecular cloning and characterization of the human A3 adenosine receptor. Proc Natl Acad Sci U S A (1993) 2.08
Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain (2003) 1.85
Direct protein kinase C-dependent phosphorylation regulates the cell surface stability and activity of the potassium chloride cotransporter KCC2. J Biol Chem (2007) 1.75
Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia. Curr Top Med Chem (2005) 1.69
NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA receptor-mediated currents. Nat Neurosci (2011) 1.65
Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain. Anesthesiology (2002) 1.63
The neuron-specific K-Cl cotransporter, KCC2. Antibody development and initial characterization of the protein. J Biol Chem (1999) 1.47
Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2. Proc Natl Acad Sci U S A (2009) 1.45
Fast synaptic inhibition in spinal sensory processing and pain control. Physiol Rev (2012) 1.45
Pharmacological and therapeutic effects of A3 adenosine receptor agonists. Drug Discov Today (2011) 1.44
G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain. Mol Pharmacol (1995) 1.40
Efficacy of synaptic inhibition depends on multiple, dynamically interacting mechanisms implicated in chloride homeostasis. PLoS Comput Biol (2011) 1.38
Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci (2010) 1.37
The role of GABA in the mediation and perception of pain. Adv Pharmacol (2006) 1.34
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem (1998) 1.32
Descending pain modulation and chronification of pain. Curr Opin Support Palliat Care (2014) 1.30
Loose ligation of the sciatic nerve is associated with TrkB receptor-dependent decreases in KCC2 protein levels in the ipsilateral spinal dorsal horn. Pain (2007) 1.29
Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J Neurosci (1997) 1.29
Pain-relieving prospects for adenosine receptors and ectonucleotidases. Trends Mol Med (2011) 1.28
Changes in GAD- and GABA- immunoreactivity in the spinal dorsal horn after peripheral nerve injury and promotion of recovery by lumbar transplant of immortalized serotonergic precursors. J Chem Neuroanat (1998) 1.26
Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions. J Med Chem (2012) 1.23
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. Brain (2014) 1.21
Controlling murine and rat chronic pain through A3 adenosine receptor activation. FASEB J (2012) 1.20
Preferential use of unobstructed lateral portals as the access route to the pore of human ATP-gated ion channels (P2X receptors). Proc Natl Acad Sci U S A (2011) 1.20
Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2. Trends Neurosci (2013) 1.20
Release of gamma-aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats. Neurosurgery (1996) 1.19
N-methyl-D-aspartate receptor- and calpain-mediated proteolytic cleavage of K+-Cl- cotransporter-2 impairs spinal chloride homeostasis in neuropathic pain. J Biol Chem (2012) 1.16
Spinal cord stimulation attenuates augmented dorsal horn release of excitatory amino acids in mononeuropathy via a GABAergic mechanism. Pain (1997) 1.16
Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2. Proc Natl Acad Sci U S A (2012) 1.12
Adenosine and ATP receptors. Handb Exp Pharmacol (2007) 1.11
Activity-dependent cleavage of the K-Cl cotransporter KCC2 mediated by calcium-activated protease calpain. J Neurosci (2012) 1.08
Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR/GPR39 receptor. J Neurosci (2011) 1.08
Microglia control neuronal network excitability via BDNF signalling. Neural Plast (2013) 1.08
Adenovector GAD65 gene delivery into the rat trigeminal ganglion produces orofacial analgesia. Mol Pain (2009) 1.07
The A3 adenosine receptor: history and perspectives. Pharmacol Rev (2015) 1.05
GABA puts a stop to pain. Curr Drug Targets CNS Neurol Disord (2004) 1.04
Visualization of lamina I of the dorsal horn in live adult rat spinal cord slices. J Neurosci Methods (2000) 1.02
GABA and bicuculline actions on mouse spinal cord and cortical neurons in cell culture. Brain Res (1982) 1.01
Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy. Brain Behav Immun (2014) 0.97
Functional regulation of gamma-aminobutyric acid transporters by direct tyrosine phosphorylation. J Biol Chem (2000) 0.96
Substrate-induced regulation of gamma-aminobutyric acid transporter trafficking requires tyrosine phosphorylation. J Biol Chem (2001) 0.96
Inhibition of KCC2 in mouse spinal cord neurons leads to hypersensitivity to thermal stimulation. Anesth Analg (2011) 0.95
GABA transporters as drug targets for modulation of GABAergic activity. Biochem Pharmacol (2004) 0.95
CREB-Dependent Regulation of GAD65 Transcription by BDNF/TrkB in Cortical Interneurons. Cereb Cortex (2010) 0.92
Is BDNF sufficient for information transfer between microglia and dorsal horn neurons during the onset of central sensitization? Mol Pain (2010) 0.92
Protein kinase C-epsilon is involved in the adenosine-activated signal transduction pathway conferring protection against ischemia-reperfusion injury in primary rat neuronal cultures. J Neurochem (2003) 0.91
A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats. Am J Pathol (2011) 0.91
Protein phosphorylation of human brain glutamic acid decarboxylase (GAD)65 and GAD67 and its physiological implications. Biochemistry (2004) 0.90
Differential GABAergic disinhibition during the development of painful peripheral neuropathy. Neuroscience (2011) 0.90
Structural probing of off-target G protein-coupled receptor activities within a series of adenosine/adenine congeners. PLoS One (2014) 0.90
Distribution of glycine/GABA neurons in the ventromedial medulla with descending spinal projections and evidence for an ascending glycine/GABA projection. PLoS One (2012) 0.89
Adenosine A2A receptors enhance GABA transport into nerve terminals by restraining PKC inhibition of GAT-1. J Neurochem (2009) 0.89
Supraspinal peroxynitrite modulates pain signaling by suppressing the endogenous opioid pathway. J Neurosci (2012) 0.86
GABA pharmacology: the search for analgesics. Neurochem Res (2014) 0.86
Upregulation of the GABA-transporter GAT-1 in the spinal cord contributes to pain behaviour in experimental neuropathy. Neurosci Lett (2008) 0.86
Intraplantar-injected ceramide in rats induces hyperalgesia through an NF-κB- and p38 kinase-dependent cyclooxygenase 2/prostaglandin E2 pathway. FASEB J (2011) 0.85
Suppressing SNAP-25 and reversing glial glutamate transporters relieves neuropathic pain in rats by ameliorating imbalanced neurotransmission. Chin Med J (Engl) (2013) 0.82
Presynaptic GABAergic inhibition regulated by BDNF contributes to neuropathic pain induction. Nat Commun (2014) 0.81
Localized adenosine signaling provides fine-tuned negative feedback over a wide dynamic range of neocortical network activities. J Neurophysiol (2014) 0.80
Gene therapy for pain. Expert Opin Biol Ther (2008) 0.80
Adenosine effects on inhibitory synaptic transmission and excitation-inhibition balance in the rat neocortex. J Physiol (2015) 0.78
Microglia disrupt mesolimbic reward circuitry in chronic pain. J Neurosci (2015) 0.93
Truncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane Substitutions. ACS Med Chem Lett (2012) 0.86
Nucleotides Acting at P2Y Receptors: Connecting Structure and Function. Mol Pharmacol (2015) 0.85
John W. Daly - An Appreciation. Heterocycles (2015) 0.77
Structure-Based Scaffold Repurposing for G Protein-Coupled Receptors: Transformation of Adenosine Derivatives into 5HT2B/5HT2C Serotonin Receptor Antagonists. J Med Chem (2016) 0.76
Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters. J Med Chem (2017) 0.75
Highly selective A3 adenosine receptor agonists relieve chronic neuropathic pain. Expert Opin Ther Pat (2017) 0.75
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy. Med Res Rev (2017) 0.75
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A 2A adenosine receptor binding site. Sci Rep (2017) 0.75
Demystifying P2Y1 Receptor Ligand Recognition through Docking and Molecular Dynamics Analyses. J Chem Inf Model (2017) 0.75
N(6)-Substituted 5'-N-Methylcarbamoyl-4'-selenoadenosines as Potent and Selective A3 Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation. J Med Chem (2017) 0.75